Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

The incidence of immunofluorescence patterns and specific autoantibodies observed in autoimmune patients in a tertiary care centre.

Chauhan R, Jain D, Dorwal P, Roy G, Raina SP, Nandi V.

Eur Ann Allergy Clin Immunol. 2019 Apr 15. doi: 10.23822/EurAnnACI.1764-1489.93. [Epub ahead of print]

PMID:
30983307
2.

A dual strategy to optimize hematopoietic progenitor cell collections: validation of a simple prediction algorithm and use of collect flow rates guided by mononuclear cell count.

Godbey EA, Dormesy S, Gowda L, Nandi V, Paradiso S, Sachais BS, Shi PA.

Transfusion. 2019 Feb;59(2):659-670. doi: 10.1111/trf.15034. Epub 2018 Dec 7.

PMID:
30537213
3.

Donor incentives improve cardiovascular disease risk profile and donation rates.

Goel R, Kessler D, Nandi V, Ortiz C, Hillyer CD, Shaz BH.

Transfusion. 2019 Jan;59(1):250-258. doi: 10.1111/trf.14989. Epub 2018 Nov 8.

PMID:
30408199
4.

Safety and efficacy of plerixafor dose escalation for the mobilization of CD34+ hematopoietic progenitor cells in patients with sickle cell disease: interim results.

Boulad F, Shore T, van Besien K, Minniti C, Barbu-Stevanovic M, Fedus SW, Perna F, Greenberg J, Guarneri D, Nandi V, Mauguen A, Yazdanbakhsh K, Sadelain M, Shi PA.

Haematologica. 2018 Sep;103(9):1577. doi: 10.3324/haematol.2018.199414. No abstract available.

5.

Prevalence and mapping of hepatitis C infections among men who have sex with men in New York City.

Tieu HV, Laeyendecker O, Nandi V, Rose R, Fernandez R, Lynch B, Hoover DR, Frye V, Koblin BA.

PLoS One. 2018 Jul 18;13(7):e0200269. doi: 10.1371/journal.pone.0200269. eCollection 2018.

6.

Post-exposure Prophylaxis Awareness, Knowledge, Access and Use Among Three Populations in New York City, 2016-17.

Koblin BA, Usher D, Nandi V, Tieu HV, Bravo E, Lucy D, Miles L, Ortiz G, Kindlon MJ, Parisi DM, Frye V.

AIDS Behav. 2018 Aug;22(8):2718-2732. doi: 10.1007/s10461-018-2175-5.

PMID:
29858737
7.

Safety and efficacy of plerixafor dose escalation for the mobilization of CD34+ hematopoietic progenitor cells in patients with sickle cell disease: interim results.

Boulad F, Shore T, van Besien K, Minniti C, Barbu-Stevanovic M, Fedus SW, Perna F, Greenberg J, Guarneri D, Nandi V, Mauguen A, Yazdanbakhsh K, Sadelain M, Shi PA.

Haematologica. 2018 May;103(5):770-777. doi: 10.3324/haematol.2017.187047. Epub 2018 Feb 1. Erratum in: Haematologica. 2018 Sep;103(9):1577.

8.

Intervention to Match Young Black Men and Transwomen Who Have Sex With Men or Transwomen to HIV Testing Options (All About Me): Protocol for a Randomized Controlled Trial.

Koblin B, Hirshfield S, Chiasson MA, Wilton L, Usher D, Nandi V, Hoover DR, Frye V.

JMIR Res Protoc. 2017 Dec 19;6(12):e254. doi: 10.2196/resprot.8856.

9.

Barriers and facilitators of HIV vaccine and prevention study participation among Young Black MSM and transwomen in New York City.

Richardson S, Seekaew P, Koblin B, Vazquez T, Nandi V, Tieu HV.

PLoS One. 2017 Jul 19;12(7):e0181702. doi: 10.1371/journal.pone.0181702. eCollection 2017.

10.

Informing the Development of a Mobile Phone HIV Testing Intervention: Intentions to Use Specific HIV Testing Approaches Among Young Black Transgender Women and Men Who Have Sex With Men.

Koblin BA, Nandi V, Hirshfield S, Chiasson MA, Hoover DR, Wilton L, Usher D, Frye V.

JMIR Public Health Surveill. 2017 Jul 7;3(3):e45. doi: 10.2196/publichealth.7397.

11.

Neighborhood determinants of mood and anxiety disorders among men who have sex with men in New York City.

Cerdá M, Nandi V, Frye V, Egan JE, Rundle A, Quinn JW, Sheehan D, Hoover DR, Ompad DC, Van Tieu H, Greene E, Koblin B.

Soc Psychiatry Psychiatr Epidemiol. 2017 Jun;52(6):749-760. doi: 10.1007/s00127-017-1379-8. Epub 2017 Apr 5.

12.

Associations Among Neighborhood Characteristics and Sexual Risk Behavior Among Black and White MSM Living in a Major Urban Area.

Frye V, Nandi V, Egan JE, Cerda M, Rundle A, Quinn JW, Sheehan D, Ompad DC, Van Tieu H, Greene E, Koblin B.

AIDS Behav. 2017 Mar;21(3):870-890. doi: 10.1007/s10461-016-1596-2.

PMID:
27817101
13.

Congruence of Home, Social and Sex Neighborhoods among Men Who Have Sex with Men, NYCM2M Study.

Koblin BA, Egan JE, Nandi V, Sang JM, Cerdá M, Tieu HV, Ompad DC, Hoover DR, Frye V.

J Urban Health. 2017 Jun;94(3):364-374. doi: 10.1007/s11524-016-0074-5.

14.

Minihepcidin peptides as disease modifiers in mice affected by β-thalassemia and polycythemia vera.

Casu C, Oikonomidou PR, Chen H, Nandi V, Ginzburg Y, Prasad P, Fleming RE, Shah YM, Valore EV, Nemeth E, Ganz T, MacDonald B, Rivella S.

Blood. 2016 Jul 14;128(2):265-76. doi: 10.1182/blood-2015-10-676742. Epub 2016 May 6.

15.

Red blood cell non-ABO-identical transfusions are harmful: really?

Yazdanbakhsh K, Nandi V.

Transfusion. 2016 Mar;56(3):543-5. doi: 10.1111/trf.13505. No abstract available.

PMID:
26954449
16.

Evidence of relative iron deficiency in platelet- and plasma-pheresis donors correlates with donation frequency.

Li H, Condon F, Kessler D, Nandi V, Rebosa M, Westerman M, Shaz BH, Ginzburg Y.

J Clin Apher. 2016 Dec;31(6):551-558. doi: 10.1002/jca.21448. Epub 2016 Feb 24.

PMID:
26915437
17.

Do Sexual Networks of Men Who Have Sex with Men in New York City Differ by Race/Ethnicity?

Tieu HV, Nandi V, Hoover DR, Lucy D, Stewart K, Frye V, Cerda M, Ompad D, Latkin C, Koblin BA; NYC M2M Study Team.

AIDS Patient Care STDS. 2016 Jan;30(1):39-47. doi: 10.1089/apc.2015.0237.

18.

Correlates of Seroadaptation Strategies Among Black Men Who have Sex with Men (MSM) in 4 US Cities.

Wilton L, Koblin B, Nandi V, Xu G, Latkin C, Seal D, Flores SA, Spikes P.

AIDS Behav. 2015 Dec;19(12):2333-46. doi: 10.1007/s10461-015-1190-z.

19.

Evaluation of Pharmacy-Based HIV Testing in a High-Risk New York City Community.

Amesty S, Crawford ND, Nandi V, Perez-Figueroa R, Rivera A, Sutton M, Weidle PJ, Willis L, Smith DK, Hernandez C, Harripersaud K, Fuller Lewis C.

AIDS Patient Care STDS. 2015 Aug;29(8):437-44. doi: 10.1089/apc.2015.0017.

PMID:
26217930
20.

Ties that bind: community attachment and the experience of discrimination among Black men who have sex with men.

Van Sluytman L, Spikes P, Nandi V, Van Tieu H, Frye V, Patterson J, Koblin B.

Cult Health Sex. 2015;17(7):859-72. doi: 10.1080/13691058.2015.1004762. Epub 2015 Feb 3.

21.

Potential involvement of Brugia malayi cysteine proteases in the maintenance of the endosymbiotic relationship with Wolbachia.

Lustigman S, Melnikow E, Anand SB, Contreras A, Nandi V, Liu J, Bell A, Unnasch TR, Rogers MB, Ghedin E.

Int J Parasitol Drugs Drug Resist. 2014 Aug 26;4(3):267-77. doi: 10.1016/j.ijpddr.2014.08.001. eCollection 2014 Dec.

22.

Sexual orientation- and race-based discrimination and sexual HIV risk behavior among urban MSM.

Frye V, Nandi V, Egan J, Cerda M, Greene E, Van Tieu H, Ompad DC, Hoover DR, Lucy D, Baez E, Koblin BA.

AIDS Behav. 2015 Feb;19(2):257-69. doi: 10.1007/s10461-014-0937-2.

23.

Altered erythropoiesis and iron metabolism in carriers of thalassemia.

Guimarães JS, Cominal JG, Silva-Pinto AC, Olbina G, Ginzburg YZ, Nandi V, Westerman M, Rivella S, de Souza AM.

Eur J Haematol. 2015 Jun;94(6):511-8. doi: 10.1111/ejh.12464. Epub 2014 Nov 11.

24.

Comparing interferon-gamma release assays to tuberculin skin test in Thai children with tuberculosis exposure.

Tieu HV, Suntarattiwong P, Puthanakit T, Chotpitayasunondh T, Chokephaibulkit K, Sirivichayakul S, Buranapraditkun S, Rungrojrat P, Chomchey N, Tsiouris S, Hammer S, Nandi V, Ananworanich J; Thai TB Px Study Group.

PLoS One. 2014 Aug 14;9(8):e105003. doi: 10.1371/journal.pone.0105003. eCollection 2014.

25.

Serial assessment of laser Doppler flow during acute pain crises in sickle cell disease.

Shi PA, Manwani D, Olowokure O, Nandi V.

Blood Cells Mol Dis. 2014 Dec;53(4):277-82. doi: 10.1016/j.bcmd.2014.04.001. Epub 2014 May 21.

26.

Concurrent partnerships and HIV risk among men who have sex with men in New York City.

Tieu HV, Nandi V, Frye V, Stewart K, Oquendo H, Bush B, Cerda M, Hoover DR, Ompad D, Koblin BA; NYC M2M Study Team.

Sex Transm Dis. 2014 Mar;41(3):200-8. doi: 10.1097/OLQ.0000000000000090.

27.

Optimization of pyrrolamides as mycobacterial GyrB ATPase inhibitors: structure-activity relationship and in vivo efficacy in a mouse model of tuberculosis.

P SH, Solapure S, Mukherjee K, Nandi V, Waterson D, Shandil R, Balganesh M, Sambandamurthy VK, Raichurkar AK, Deshpande A, Ghosh A, Awasthy D, Shanbhag G, Sheikh G, McMiken H, Puttur J, Reddy J, Werngren J, Read J, Kumar M, R M, Chinnapattu M, Madhavapeddi P, Manjrekar P, Basu R, Gaonkar S, Sharma S, Hoffner S, Humnabadkar V, Subbulakshmi V, Panduga V.

Antimicrob Agents Chemother. 2014;58(1):61-70. doi: 10.1128/AAC.01751-13. Epub 2013 Oct 14. Erratum in: Antimicrob Agents Chemother. 2014 Aug;58(8):4993-4.

28.

The integration of high-throughput testing of blood donors for cardiovascular disease risk assessment and prevention.

Kessler DA, Grima KM, Valinsky JE, Ortiz C, Hillyer CD, Nandi V, Jones RL, Shaz BH.

Transfus Apher Sci. 2013 Oct;49(2):263-7. doi: 10.1016/j.transci.2013.06.018. Epub 2013 Jul 19.

PMID:
23876998
29.

Effects of an enhanced discharge planning intervention for hospitalized older adults: a randomized trial.

Altfeld SJ, Shier GE, Rooney M, Johnson TJ, Golden RL, Karavolos K, Avery E, Nandi V, Perry AJ.

Gerontologist. 2013 Jun;53(3):430-40. doi: 10.1093/geront/gns109. Epub 2012 Sep 7.

PMID:
22961467
30.

Cardiovascular disease risk assessment and prevention in blood donors.

Kessler DA, Ortiz C, Grima K, Vlahov D, Nandi V, Jones R, Hillyer CD, Shaz BH.

Transfusion. 2012 Oct;52(10):2174-82. doi: 10.1111/j.1537-2995.2011.03549.x. Epub 2012 Feb 10.

PMID:
22320854
31.

Beyond income: material resources among drug users in economically-disadvantaged New York City neighborhoods.

Ompad DC, Nandi V, Cerdá M, Crawford N, Galea S, Vlahov D.

Drug Alcohol Depend. 2012 Jan 1;120(1-3):127-34. doi: 10.1016/j.drugalcdep.2011.07.008. Epub 2011 Aug 10.

32.

Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients.

Vergara-Rodriguez P, Tozzi MJ, Botsko M, Nandi V, Altice F, Egan JE, O'Connor PG, Sullivan LE, Fiellin DA; BHIVES Collaborative.

J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S62-7. doi: 10.1097/QAI.0b013e31820a820f.

PMID:
21317596
33.

Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics.

Korthuis PT, Tozzi MJ, Nandi V, Fiellin DA, Weiss L, Egan JE, Botsko M, Acosta A, Gourevitch MN, Hersh D, Hsu J, Boverman J, Altice FL; BHIVES Collaborative.

J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S39-45. doi: 10.1097/QAI.0b013e318209754c.

34.

HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.

Altice FL, Bruce RD, Lucas GM, Lum PJ, Korthuis PT, Flanigan TP, Cunningham CO, Sullivan LE, Vergara-Rodriguez P, Fiellin DA, Cajina A, Botsko M, Nandi V, Gourevitch MN, Finkelstein R; BHIVES Collaborative.

J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S22-32. doi: 10.1097/QAI.0b013e318209751e.

35.

HIV risk behaviors among young drug using women who have sex with women (WSWs) in New York City.

Ompad DC, Friedman SR, Hwahng SJ, Nandi V, Fuller CM, Vlahov D.

Subst Use Misuse. 2011;46(2-3):274-84. doi: 10.3109/10826084.2011.523284.

PMID:
21303247
36.

Comparison of HIV risk by duration of injection drug use.

Vlahov D, Ompad DC, Fuller CM, Nandi V.

Subst Use Misuse. 2011;46(2-3):181-91. doi: 10.3109/10826084.2011.521466.

PMID:
21303238
37.

Intimate partner violence and consistent condom use among drug-using heterosexual women in New York City.

Panchanadeswaran S, Frye V, Nandi V, Galea S, Vlahov D, Ompad D.

Women Health. 2010 Mar;50(2):107-24. doi: 10.1080/03630241003705151.

38.

Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis.

Makarov V, Manina G, Mikusova K, Möllmann U, Ryabova O, Saint-Joanis B, Dhar N, Pasca MR, Buroni S, Lucarelli AP, Milano A, De Rossi E, Belanova M, Bobovska A, Dianiskova P, Kordulakova J, Sala C, Fullam E, Schneider P, McKinney JD, Brodin P, Christophe T, Waddell S, Butcher P, Albrethsen J, Rosenkrands I, Brosch R, Nandi V, Bharath S, Gaonkar S, Shandil RK, Balasubramanian V, Balganesh T, Tyagi S, Grosset J, Riccardi G, Cole ST.

Science. 2009 May 8;324(5928):801-4. doi: 10.1126/science.1171583. Epub 2009 Mar 19.

39.

Epidemiology of subway-related fatalities in New York City, 1990-2003.

Gershon RR, Pearson JM, Nandi V, Vlahov D, Bucciarelli-Prann A, Tracy M, Tardiff K, Galea S.

J Safety Res. 2008;39(6):583-8. doi: 10.1016/j.jsr.2008.10.004. Epub 2008 Nov 14. Erratum in: J Safety Res. 2009;40(1):75.

40.

Household density among undocumented Mexican immigrants in New York City.

Standish K, Nandi V, Ompad DC, Momper S, Galea S.

J Immigr Minor Health. 2010 Jun;12(3):310-8. doi: 10.1007/s10903-008-9175-x. Epub 2008 Aug 15.

PMID:
18709456
41.

The prevalence and types of gambling among undocumented Mexican immigrants in New York City.

Momper SL, Nandi V, Ompad DC, Delva J, Galea S.

J Gambl Stud. 2009 Mar;25(1):49-65. doi: 10.1007/s10899-008-9105-9. Epub 2008 Aug 14.

42.

Evaluation of a naloxone distribution and administration program in New York City.

Piper TM, Stancliff S, Rudenstine S, Sherman S, Nandi V, Clear A, Galea S.

Subst Use Misuse. 2008;43(7):858-70. doi: 10.1080/10826080701801261.

PMID:
18570021
43.

Access to and use of health services among undocumented Mexican immigrants in a US urban area.

Nandi A, Galea S, Lopez G, Nandi V, Strongarone S, Ompad DC.

Am J Public Health. 2008 Nov;98(11):2011-20. doi: 10.2105/AJPH.2006.096222. Epub 2008 Jan 2.

44.

Hunger and health among undocumented Mexican migrants in a US urban area.

Hadley C, Galea S, Nandi V, Nandi A, Lopez G, Strongarone S, Ompad D.

Public Health Nutr. 2008 Feb;11(2):151-8. Epub 2007 Jul 5.

PMID:
17610762
45.

Urban as a determinant of health.

Vlahov D, Freudenberg N, Proietti F, Ompad D, Quinn A, Nandi V, Galea S.

J Urban Health. 2007 May;84(3 Suppl):i16-26.

46.

Overdose prevention for injection drug users: lessons learned from naloxone training and distribution programs in New York City.

Piper TM, Rudenstine S, Stancliff S, Sherman S, Nandi V, Clear A, Galea S.

Harm Reduct J. 2007 Jan 25;4:3.

47.

Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy.

Shandil RK, Jayaram R, Kaur P, Gaonkar S, Suresh BL, Mahesh BN, Jayashree R, Nandi V, Bharath S, Balasubramanian V.

Antimicrob Agents Chemother. 2007 Feb;51(2):576-82. Epub 2006 Dec 4.

48.

Drug-drug interactions of anti-infective drugs: utility of fluorescence cyp inhibition assays in drug discovery.

Fridén M, Vanaja K, Nandi VN.

Drug Metabol Drug Interact. 2006;21(3-4):163-85.

PMID:
16841512
49.

Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City.

Galea S, Worthington N, Piper TM, Nandi VV, Curtis M, Rosenthal DM.

Addict Behav. 2006 May;31(5):907-12. Epub 2005 Sep 1.

PMID:
16139434
50.

Isoniazid pharmacokinetics-pharmacodynamics in an aerosol infection model of tuberculosis.

Jayaram R, Shandil RK, Gaonkar S, Kaur P, Suresh BL, Mahesh BN, Jayashree R, Nandi V, Bharath S, Kantharaj E, Balasubramanian V.

Antimicrob Agents Chemother. 2004 Aug;48(8):2951-7.

Supplemental Content

Support Center